N4 Pharma Plc (FRA:0GO)

Germany · Delayed Price · Currency is EUR

0.0010

0.00 (0.00%)

Last updated: Feb 23, 2026, 8:22 AM CET

Revenue by Segment

Financials in millions GBP. Fiscal year is January - December.

Millions GBP. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
Development and Commercialisation of Medicines Via Its Delivery System Called Nuvec	7.28K	1.95K	-				72.83K	109.91K
Development and Commercialisation of Medicines Via Its Delivery System Called Nuvec Growth	272.86%	-	-				-33.74%	-
Total	7.28K	1.95K	-				72.83K	109.91K
Total Growth	272.86%	-	-				-33.74%	-

Revenue by Geography

Financials in millions GBP. Fiscal year is January - December.

Millions GBP. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
United Kingdom	7.28K	1.95K	-				72.83K	109.91K
United Kingdom Growth	272.86%	-	-				-33.74%	-
Total	7.28K	1.95K	-				72.83K	109.91K
Total Growth	272.86%	-	-				-33.74%	-

Source: S&P Global Market Intelligence.